Announcements
Drinks
![Scope affirms BBB+/Stable issuer rating on Hungarian pharmaceutical company Richter Gedeon](https://www.scopegroup.com/ScopeOneApi/images/announcement-img?imageName=mitteilung_96f102297c63d477f2d5a39f1f1639400f8df351308b5cb5e4eddd8ad416dcaa.jpg)
23/4/2024 Rating announcement EN
Scope affirms BBB+/Stable issuer rating on Hungarian pharmaceutical company Richter Gedeon
The affirmation mainly reflects the still very strong financial risk profile as well as the good prospects for growth and cash generation despite macroeconomic challenges and geopolitical uncertainties.
![Scope affirms BBB+/Stable issuer rating on Hungarian pharmaceutical company Richter Gedeon](https://www.scopegroup.com/ScopeOneApi/images/announcement-img?imageName=mitteilung_600d01f76c82ce60ec8d68b86d29eee7a35c7af31ce4a09c872b27dc1a462f32.jpg)
26/4/2023 Rating announcement EN
Scope affirms BBB+/Stable issuer rating on Hungarian pharmaceutical company Richter Gedeon
The affirmation mainly reflects the still strong financial risk profile as well as the good prospects for growth and cash generation despite macroeconomic and geopolitical challenges.
![Scope affirms BBB+/Stable issuer rating on Hungarian pharmaceutical company Richter Gedeon](https://www.scopegroup.com/ScopeOneApi/images/announcement-img?imageName=mitteilung_bd367d31a686a994156a07d65bd72ad8db239ae43db4154cb826f2f1977a1601.jpg)
3/5/2022 Rating announcement EN
Scope affirms BBB+/Stable issuer rating on Hungarian pharmaceutical company Richter Gedeon
The affirmation mainly reflects a continued strong financial risk profile as well as good prospects for growth and cash generation despite potential disruption from the Russian and Ukrainian business.
![Scope assigns first-time issuer rating of BBB+/Stable to Hungarian pharma Gedeon Richter](https://www.scopegroup.com/ScopeOneApi/images/announcement-img?imageName=mitteilung_8a78e7c25435f27b524a2f73b95656aadf855471b4cc7e20076ccecf3bef707c.jpg)
26/5/2021 Rating announcement EN
Scope assigns first-time issuer rating of BBB+/Stable to Hungarian pharma Gedeon Richter
The issuer credit rating mainly reflects the strong financial risk profile, solid competitive position in speciality innovative and generic pharmaceuticals, and good prospects for growth and cash generation.